These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 39411305)

  • 1. Efficacy of Polymyxin B Hemoperfusion for Treatment of Sepsis.
    Ghosh I; Sangha S; Pandey G; Srivastava A
    Indian J Crit Care Med; 2024 Oct; 28(10):930-934. PubMed ID: 39411305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients.
    Srisawat N; Tungsanga S; Lumlertgul N; Komaenthammasophon C; Peerapornratana S; Thamrongsat N; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S; Tungsanga K; Kellum JA
    Crit Care; 2018 Oct; 22(1):279. PubMed ID: 30367647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.
    Cruz DN; Antonelli M; Fumagalli R; Foltran F; Brienza N; Donati A; Malcangi V; Petrini F; Volta G; Bobbio Pallavicini FM; Rottoli F; Giunta F; Ronco C
    JAMA; 2009 Jun; 301(23):2445-52. PubMed ID: 19531784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of a risk stratification-based model for prediction of acute kidney injury combined with hemoperfusion in patients with sepsis: a prospective, observational, pilot study].
    Feng F; Chen Y; Chen W; Yang H; Yang W; Du J; Li M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jul; 32(7):814-818. PubMed ID: 32788015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial.
    Dellinger RP; Bagshaw SM; Antonelli M; Foster DM; Klein DJ; Marshall JC; Palevsky PM; Weisberg LS; Schorr CA; Trzeciak S; Walker PM;
    JAMA; 2018 Oct; 320(14):1455-1463. PubMed ID: 30304428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column.
    Huang Z; Wang SR; Su W; Liu JY
    Ther Apher Dial; 2010 Dec; 14(6):596-602. PubMed ID: 21118369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis.
    Chang T; Tu YK; Lee CT; Chao A; Huang CH; Wang MJ; Yeh YC
    Crit Care Med; 2017 Aug; 45(8):e858-e864. PubMed ID: 28445237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PMX endotoxin removal in the clinical practice: results from the EUPHAS trial.
    Antonelli M; Fumagalli R; Cruz DN; Brienza N; Giunta F
    Contrib Nephrol; 2010; 167():83-90. PubMed ID: 20519902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Extended Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion on Hemodynamics, Vasoactive Substance Requirement, and Pulmonary Oxygenation in Patients with Sepsis: An Observational Study.
    Mitaka C; Kusao M; Kawagoe I; Satoh D; Iba T; Ronco C
    Blood Purif; 2022; 51(1):62-69. PubMed ID: 33910191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection.
    Saito N; Sugiyama K; Ohnuma T; Kanemura T; Nasu M; Yoshidomi Y; Tsujimoto Y; Adachi H; Koami H; Tochiki A; Hori K; Wagatsuma Y; Matsumoto H
    PLoS One; 2017; 12(3):e0173633. PubMed ID: 28358803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of polymyxin B hemoperfusion in the treatment of patients with sepsis and septic shock: a meta-analysis of randomized controlled trials.
    Kuriyama A; Katsura M; Urushidani S; Takada T
    Ann Transl Med; 2018 Jun; 6(11):206. PubMed ID: 30023369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Effects and Outcomes After Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Treatment for Septic Shock in Preterm Neonates.
    Nishizaki N; Hara T; Obinata K; Nakagawa M; Shimizu T
    Pediatr Crit Care Med; 2020 Feb; 21(2):156-163. PubMed ID: 31568052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of PIRO, APACHE IV, and SOFA Scores in Predicting Outcome in Patients with Sepsis Admitted to Intensive Care Unit: A Two-year Cross-sectional Study at Rural Teaching Hospital.
    Dronamraju S; Agrawal S; Kumar S; Acharya S; Gaidhane S; Wanjari A; Jaiswal P; Bawiskar N
    Indian J Crit Care Med; 2022 Oct; 26(10):1099-1105. PubMed ID: 36876200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection.
    Vincent JL; Laterre PF; Cohen J; Burchardi H; Bruining H; Lerma FA; Wittebole X; De Backer D; Brett S; Marzo D; Nakamura H; John S
    Shock; 2005 May; 23(5):400-5. PubMed ID: 15834304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyxin B Hemoperfusion in Sepsis: A Possible Silver Lining to the Dark Clouds?
    Sharma J; Khatav SK
    Indian J Crit Care Med; 2024 Oct; 28(10):903-905. PubMed ID: 39411302
    [No Abstract]   [Full Text] [Related]  

  • 16. Postoperative polymyxin B hemoperfusion and mortality in patients with abdominal septic shock: a propensity-matched analysis.
    Iwagami M; Yasunaga H; Doi K; Horiguchi H; Fushimi K; Matsubara T; Yahagi N; Noiri E
    Crit Care Med; 2014 May; 42(5):1187-93. PubMed ID: 24365858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polymyxin-B direct hemoperfusion (PMX-DHP) in gram negative sepsis].
    Perego AF; Morabito S; Graziani G; Casella GP; Parodi O
    G Ital Nefrol; 2006; 23 Suppl 36():S94-102. PubMed ID: 17068736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymyxin B hemoperfusion in clinical practice: the picture from an unbound collaborative registry.
    Early Use of Polymyxin B Hemoperfusion in the Abdominal Sepsis 2 Collaborative Group
    Blood Purif; 2014; 37 Suppl 1():22-5. PubMed ID: 24457492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of Different Blood Biomarkers during Polymyxin-B Extracorporeal Hemoperfusion in Abdominal Sepsis.
    Cotoia A; Parisano V; Mariotti PS; Lizzi V; Netti GS; Ranieri E; Forfori F; Cinnella G
    Blood Purif; 2024; 53(7):574-582. PubMed ID: 38653211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hemoperfusion with polymyxin B added to hemofiltration in patients with endotoxic shock: a case-control study.
    Navas A; Ferrer R; Martínez ML; Gomà G; Gili G; Masip J; Suárez D; Artigas A
    Ann Intensive Care; 2018 Dec; 8(1):121. PubMed ID: 30535929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.